Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide-Reference-Cited by-同舟云学术

Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide

Published:2017-03-28 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Branquinho Renata Tupinambá,Roy Jérôme,Farah Charlotte,Garcia Giani Martins,Aimond Franck,Le Guennec Jean-Yves,Saude-Guimarães Dênia Antunes,Grabe-Guimaraes Andrea,Mosqueira Vanessa Carla Furtado,de Lana Marta,Richard Sylvain

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep44998.pdf

Reference59 articles.

1. Nunes, M. C. P. et al. Chagas disease: an overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 62, 767–776 (2013).

2. Prata, A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1, 92–100 (2001).

3. Rassi, A., Rassi, A. & Marin-Neto, J. A. Chagas disease. Lancet 375, 1388–1402 (2010).

4. Ribeiro, A. L., Nunes, M. P., Teixeira, M. M. & Rocha, M. O. C. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9, 576–589 (2012).

5. Biolo, A., Ribeiro, A. L. & Clausell, N. Chagas cardiomyopathy–where do we stand after a hundred years? Prog Cardiovasc Dis 52, 300–316 (2010).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status;Expert Opinion on Investigational Drugs;2024-05-14

2. Nanomedicines against Chagas disease: a critical review;Beilstein Journal of Nanotechnology;2024-03-27

3. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action;Experimental Parasitology;2023-12

4. Quality by design for the synthesis and optimisation of arginine-poly(ester-amide) nanocapsules as promising carriers for nose-brain delivery of carbamazepine;Journal of Drug Delivery Science and Technology;2023-11

5. Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease;Pharmaceuticals;2023-08-15